CD14 and relapsing-remitting multiple sclerosis: For example, one study reported increased levels of M-MDSCs (CD14+HLA-DR-/low) in the peripheral blood of RRMS patients [39], whereas another study that defined M-MDSCs as CD14+CD15-CD33+HLA-DR- cells reported opposite findings [40].